Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
failed trials
Biotech
Novo Nordisk discards $1.3B kidney drug in wake of phase 3 fail
Novo Nordisk, after mulling the implications of a phase 3 fail, has given up on a late-stage kidney drug acquired in a $1.3 billion deal.
James Waldron
Nov 6, 2024 4:54am
Essa drops lead cancer drug after falling short against Xtandi
Nov 1, 2024 7:33am
UCB's tau drug flunks Alzheimer's trial days after Roche's exit
Nov 1, 2024 6:01am
Spero speared by antibiotic flop, triggering 39% workforce cut
Oct 30, 2024 6:30am
GemVax's peptide drug fails phase 2a neurodegenerative trial
Oct 29, 2024 11:28am
Alto's midphase depression trial falls flat
Oct 23, 2024 4:47am
